Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NSE India Stock Exchange  >  Suven Life Sciences Limited    SUVEN   INE495B01038

SUVEN LIFE SCIENCES LIMITED

(SUVEN)
  Report
SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
The feature you requested does not exist. However, we suggest the following feature:

SUVEN LIFE SCIENCES LTD. : Ex-dividend day for interim dividend

share with twitter share with LinkedIn share with facebook
02/14/2019 EDT
An interim dividend is removed today from Suven Life Sciences Ltd.'s share.


© Factset 2019
share with twitter share with LinkedIn share with facebook
All news about SUVEN LIFE SCIENCES LIMITE
01/21SUVEN LIFE SCIENCES LTD : Spin off
FA
2019SUVEN LIFE SCIENCES : receives EIR from US FDA for its Pashamylaram facility
AQ
2019SUVEN LIFE SCIENCES : announces Top-Line Results of SUVN-502 Phase 2A Study in P..
AQ
2019SUVEN LIFE SCIENCES LTD TO HOST Q2 A : 30 am IST
AQ
2011SUVEN LIFE SCIENCES LTD. : Suven Life Sciences secures 4 Product Patents for the..
PU
2011SUVEN LIFE SCIENCES LTD. : Suven Life Sciences secures 4 Product Patents for the..
PU
2011SUVEN LIFE SCIENCES LTD. : Suven presenting at International Conference on Alzhe..
PU
2011SUVEN LIFE SCIENCES LTD. : Suven Life Sciences secures 2 Product Patents for the..
PU
More news
Financials
Sales 2020 8 559 M 114 M 114 M
Net income 2020 2 177 M 29,1 M 29,1 M
Net Debt 2020 - - -
P/E ratio 2020 3,06x
Yield 2020 -
Capitalization 6 657 M 89,0 M 89,0 M
Capi. / Sales 2020 0,78x
Capi. / Sales 2021 0,72x
Nbr of Employees -
Free-Float 37,9%
Chart SUVEN LIFE SCIENCES LIMITED
Duration : Period :
Suven Life Sciences Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 52,30 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Venkateswarlu Jasti Chairman & Chief Executive Officer
M. Mohan Kumar Chief Financial Officer
C. Rajendiran Director-Research & Development
Sudha Rani Jasti Executive Director
Rangaswamy Naidu Maripuri Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SUVEN LIFE SCIENCES LIMITED-82.97%81
JOHNSON & JOHNSON0.75%394 028
ROCHE HOLDING AG1.08%297 694
PFIZER, INC.-2.17%212 995
MERCK & CO., INC.-9.09%209 118
NOVARTIS AG-15.76%187 147